Li Li, Qiao-Wei Wu, Bu-Lang Gao, Qiu-Ji Shao, Tian-Xiao Li, Hang Li, Liang-Fu Zhu
{"title":"血流分流术治疗颅内大、巨未破裂动脉瘤的安全性及效果。","authors":"Li Li, Qiao-Wei Wu, Bu-Lang Gao, Qiu-Ji Shao, Tian-Xiao Li, Hang Li, Liang-Fu Zhu","doi":"10.1111/ans.70221","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the safety and effect of flow diverters in the management of large and giant unruptured intracranial aneurysms and risk factors for complete aneurysm occlusion at a long-term follow-up.</p><p><strong>Materials and methods: </strong>Patients with large and giant unruptured intracranial aneurysms treated with flow diverters (Pipeline and Tubridge embolization devices) were retrospectively enrolled. The clinical data, peri-procedural complications, occlusion status of aneurysms, and factors affecting aneurysm occlusion were analyzed. Subanalyses between large and giant aneurysms or between saccular and fusiform aneurysms were also performed.</p><p><strong>Results: </strong>Ninety-two patients with 95 intracranial aneurysms were enrolled. Most aneurysms involved the internal carotid artery (77.9%). The size of the aneurysm was 10-25 mm in 81 (85.3%) and > 25 mm in 14 (14.7%). The procedure was successful in all patients (100%). At discharge, the mRS was 0 in 72 (78.3%) patients, 1 in 15 (16.3%), 2 in three (3.3%), 3 in one (1.1%), and 6 in one (1.1%). Four patients (4.3%) who had undergone PED (Pipeline embolization device) implantation experienced post-procedural complications. Follow-up was performed in 77 (83.7%) patients 6-65 (median 39) months after embolization, and 55 (71.4%) patients with 56 aneurysms experienced imaging follow-up. At the last angiographic follow-up 6-62 months (median 37) after the procedure, four (7.1% or 4/56) patients had instent stenosis, and total aneurysm occlusion with OKM (O'Kelly-Marotta) grade D was in 45 aneurysms (80.4%). Flow diverter combined with coiling is a single independent factor affecting complete aneurysm occlusion (OR = 8.98, 95% CI 1.87-43.22, p = 0.006). In subanalysis, the treatment modality was significantly (p = 0.04) different in the large versus giant aneurysms, with diversion plus coiling being performed in all 14 giant aneurysms but only in 43 (53.1%) large ones. Follow-up angiographic occlusion of aneurysms was significantly (p = 0.04) better in giant aneurysms than in large ones.</p><p><strong>Conclusion: </strong>The Pipeline and Tubridge flow diverting devices seem safe and effective in the treatment of large and giant unruptured intracranial aneurysms, and flow diverter combined with coiling is an independent risk factor for complete aneurysm occlusion at the long-term follow-up even though serious peri-procedural complications remain to be solved.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Safety and Effect of Flow Diverters in the Management of Large and Giant Unruptured Intracranial Aneurysms.\",\"authors\":\"Li Li, Qiao-Wei Wu, Bu-Lang Gao, Qiu-Ji Shao, Tian-Xiao Li, Hang Li, Liang-Fu Zhu\",\"doi\":\"10.1111/ans.70221\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To investigate the safety and effect of flow diverters in the management of large and giant unruptured intracranial aneurysms and risk factors for complete aneurysm occlusion at a long-term follow-up.</p><p><strong>Materials and methods: </strong>Patients with large and giant unruptured intracranial aneurysms treated with flow diverters (Pipeline and Tubridge embolization devices) were retrospectively enrolled. The clinical data, peri-procedural complications, occlusion status of aneurysms, and factors affecting aneurysm occlusion were analyzed. Subanalyses between large and giant aneurysms or between saccular and fusiform aneurysms were also performed.</p><p><strong>Results: </strong>Ninety-two patients with 95 intracranial aneurysms were enrolled. Most aneurysms involved the internal carotid artery (77.9%). The size of the aneurysm was 10-25 mm in 81 (85.3%) and > 25 mm in 14 (14.7%). The procedure was successful in all patients (100%). At discharge, the mRS was 0 in 72 (78.3%) patients, 1 in 15 (16.3%), 2 in three (3.3%), 3 in one (1.1%), and 6 in one (1.1%). Four patients (4.3%) who had undergone PED (Pipeline embolization device) implantation experienced post-procedural complications. Follow-up was performed in 77 (83.7%) patients 6-65 (median 39) months after embolization, and 55 (71.4%) patients with 56 aneurysms experienced imaging follow-up. At the last angiographic follow-up 6-62 months (median 37) after the procedure, four (7.1% or 4/56) patients had instent stenosis, and total aneurysm occlusion with OKM (O'Kelly-Marotta) grade D was in 45 aneurysms (80.4%). Flow diverter combined with coiling is a single independent factor affecting complete aneurysm occlusion (OR = 8.98, 95% CI 1.87-43.22, p = 0.006). In subanalysis, the treatment modality was significantly (p = 0.04) different in the large versus giant aneurysms, with diversion plus coiling being performed in all 14 giant aneurysms but only in 43 (53.1%) large ones. Follow-up angiographic occlusion of aneurysms was significantly (p = 0.04) better in giant aneurysms than in large ones.</p><p><strong>Conclusion: </strong>The Pipeline and Tubridge flow diverting devices seem safe and effective in the treatment of large and giant unruptured intracranial aneurysms, and flow diverter combined with coiling is an independent risk factor for complete aneurysm occlusion at the long-term follow-up even though serious peri-procedural complications remain to be solved.</p>\",\"PeriodicalId\":8158,\"journal\":{\"name\":\"ANZ Journal of Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-06-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ANZ Journal of Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/ans.70221\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ANZ Journal of Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ans.70221","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
摘要
目的:探讨分流术治疗颅内大、巨型未破裂动脉瘤的安全性和疗效,以及动脉瘤完全闭塞的危险因素。材料和方法:回顾性分析采用分流器(管道和导管栓塞装置)治疗的颅内大、巨型未破裂动脉瘤患者。分析临床资料、术中并发症、动脉瘤闭塞情况及影响动脉瘤闭塞的因素。对大动脉瘤和巨动脉瘤、囊状动脉瘤和梭状动脉瘤进行亚分析。结果:纳入92例颅内动脉瘤,共95例。大多数动脉瘤累及颈内动脉(77.9%)。动脉瘤大小10- 25mm 81例(85.3%),> - 25mm 14例(14.7%)。所有患者手术成功(100%)。出院时,72例(78.3%)患者的mRS为0,15例(16.3%)患者为1,3例(3.3%)患者为2,1例(1.1%)患者为3,1例(1.1%)患者为6。4例(4.3%)行PED(管道栓塞装置)植入术后出现并发症。栓塞后6 ~ 65个月(中位39个月)随访77例(83.7%),56个动脉瘤55例(71.4%)行影像学随访。在术后6-62个月(中位37个月)的最后一次血管造影随访中,4例(7.1%或4/56)患者出现了静脉狭窄,45例(80.4%)动脉瘤完全闭塞为OKM (O'Kelly-Marotta) D级。分流器联合绕线是影响动脉瘤完全闭塞的唯一独立因素(OR = 8.98, 95% CI 1.87 ~ 43.22, p = 0.006)。在亚分析中,大动脉瘤与巨动脉瘤的治疗方式差异有统计学意义(p = 0.04), 14个巨动脉瘤均行转移+绕线术,而43个大动脉瘤(53.1%)行转移+绕线术。巨动脉瘤的随访血管造影闭塞效果明显优于大动脉瘤(p = 0.04)。结论:Pipeline and Tubridge分流器治疗颅内大、巨未破裂动脉瘤安全有效,分流器联合盘绕术在长期随访中是动脉瘤完全闭塞的独立危险因素,但术中严重并发症仍有待解决。
Safety and Effect of Flow Diverters in the Management of Large and Giant Unruptured Intracranial Aneurysms.
Purpose: To investigate the safety and effect of flow diverters in the management of large and giant unruptured intracranial aneurysms and risk factors for complete aneurysm occlusion at a long-term follow-up.
Materials and methods: Patients with large and giant unruptured intracranial aneurysms treated with flow diverters (Pipeline and Tubridge embolization devices) were retrospectively enrolled. The clinical data, peri-procedural complications, occlusion status of aneurysms, and factors affecting aneurysm occlusion were analyzed. Subanalyses between large and giant aneurysms or between saccular and fusiform aneurysms were also performed.
Results: Ninety-two patients with 95 intracranial aneurysms were enrolled. Most aneurysms involved the internal carotid artery (77.9%). The size of the aneurysm was 10-25 mm in 81 (85.3%) and > 25 mm in 14 (14.7%). The procedure was successful in all patients (100%). At discharge, the mRS was 0 in 72 (78.3%) patients, 1 in 15 (16.3%), 2 in three (3.3%), 3 in one (1.1%), and 6 in one (1.1%). Four patients (4.3%) who had undergone PED (Pipeline embolization device) implantation experienced post-procedural complications. Follow-up was performed in 77 (83.7%) patients 6-65 (median 39) months after embolization, and 55 (71.4%) patients with 56 aneurysms experienced imaging follow-up. At the last angiographic follow-up 6-62 months (median 37) after the procedure, four (7.1% or 4/56) patients had instent stenosis, and total aneurysm occlusion with OKM (O'Kelly-Marotta) grade D was in 45 aneurysms (80.4%). Flow diverter combined with coiling is a single independent factor affecting complete aneurysm occlusion (OR = 8.98, 95% CI 1.87-43.22, p = 0.006). In subanalysis, the treatment modality was significantly (p = 0.04) different in the large versus giant aneurysms, with diversion plus coiling being performed in all 14 giant aneurysms but only in 43 (53.1%) large ones. Follow-up angiographic occlusion of aneurysms was significantly (p = 0.04) better in giant aneurysms than in large ones.
Conclusion: The Pipeline and Tubridge flow diverting devices seem safe and effective in the treatment of large and giant unruptured intracranial aneurysms, and flow diverter combined with coiling is an independent risk factor for complete aneurysm occlusion at the long-term follow-up even though serious peri-procedural complications remain to be solved.
期刊介绍:
ANZ Journal of Surgery is published by Wiley on behalf of the Royal Australasian College of Surgeons to provide a medium for the publication of peer-reviewed original contributions related to clinical practice and/or research in all fields of surgery and related disciplines. It also provides a programme of continuing education for surgeons. All articles are peer-reviewed by at least two researchers expert in the field of the submitted paper.